The Respiratory Laboratory at the Guam Memorial Hospital Authority has earned recertification of its respiratory services ...
Lumos Diagnostics has kicked off a key paediatric study in the US for its FebriDx rapid diagnostic test, marking a ...
CLIA celebrates Expedition Week as part of 2025 Cruise Month, highlighting the surging popularity of remote and pristine locations.
GeneDx announces that the FDA has granted Breakthrough Device Designation for its whole genome and exome tests.
Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30, 2025, before the market opens on Tuesday, November 4, ...
LetsGetChecked offers a range of multiple STI tests in collaboration with CLIA-certified laboratories. This test can identify the five most common STIs, making it a good option for those who want to ...
It was a weaker, er, week for healthcare stocks on the ASX, but takeover bids, trials and expansion deals kept the sector’s ...
During the ongoing federal government shutdown, many Medicare-related survey and certification activities for nursing homes ...
Stockhead on MSN
ASX Quarterly Health Wrap: Lumos lands US$317m deal as ReNerve and Vitrafy hit key milestones
In partnership with the U.S. Army Institute of Surgical Research (USAISR), Vitrafy began the second phase of its platelet ...
YD Bio Limited (“YD Bio” or the “Company”) (NasdaqGM: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today rang the Opening ...
Crisis pregnancy centers, or anti-abortion organizations that try to prevent customers from accessing abortion and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results